Intestinal epithelial barrier and neuromuscular compartment in health and disease

doi:10.3748/wjg.v26.i14.1564

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 26, Issue 14

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (23256)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-1) series, Tables (1-3) series.

Item

Count

PDF

826

WORD

224

HTML

19580

Figures (1-1)

654

Tables (1-3)

362

Sum=21646

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

731

Download

879

Sum=1610

Apr 14, 2020 (publication date) through Nov 5, 2024

Times Cited of This Article

Times Cited (34)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Review

World J Gastroenterol. Apr 14, 2020; 26(14): 1564-1579
Published online Apr 14, 2020. doi: 10.3748/wjg.v26.i14.1564

Table 2 Summary of current human and experimental data on molecular, morphological and functional changes in intestinal epithelial barrier and neuromuscular compartment in metabolic disorders

Metabolic disorder	Morphofunctional changes in intestinal epithelial barrier	Morphofunctional changes in enteric neuromuscular compartment	Ref.
Human investigations
Obesity	↑ Circulating LPS	NA	[6]
	↓ Occludin and tri-cellulin immunopositivity
	↑ ZO-1
Diabetes	↑ Intestinal permeability (urinary excretion of lactulose)	NA	[6]
Experimental models
HFD-induced obese mice	↓ ZO-1, occludin and claudins	↓ Nitrergic and VIPergic neurons Altered smooth muscle cell excitability	[89-91,93,94,96,97]
	↑ Circulating LPS	↓ Enteric inhibitory neurotransmission
		↑ Enteric excitatory tachykininergic neurotransmission
		↑ SP immunopositivity
		↑ A_2B adenosine receptor expression
Lep ob/ob mice	↑ Intestinal permeability	NA	[92]
	Alterations of villi/crypt length
	↓ TJs and mucus-related genes
Ob/ob mice	↑ Paracellular permeability	↓ Intestinal motor activity	[95]
	Altered TJs	↓ ACh receptors
	Altered TJs	Delayed intestinal transit rate

↑: Increase; ↓: Decrease; A_2B: Adenosine 2B receptor; Ach: Acetylcholine; HFD: High-fat diet; Lep: Leptin; LPS: Lipopolysaccharide; NA: Not available; Ob/ob: Obese mice; SP: Substance P; TJ: Tight junction; ZO-1: Zonulin-1.

Citation: D’Antongiovanni V, Pellegrini C, Fornai M, Colucci R, Blandizzi C, Antonioli L, Bernardini N. Intestinal epithelial barrier and neuromuscular compartment in health and disease. World J Gastroenterol 2020; 26(14): 1564-1579
URL: https://www.wjgnet.com/1007-9327/full/v26/i14/1564.htm
DOI: https://dx.doi.org/10.3748/wjg.v26.i14.1564